Philadelphia, PANCT07389473Now EnrollingIRB Ready

ADHD Clinical Trial in Philadelphia, PA

Access cutting-edge adhd treatment through this clinical trial at a research site in Philadelphia. Study-provided care at no cost to qualified participants.

Sponsored by Gaize

Quick Self-Assessment

See if you qualify for this Philadelphia location

Preparing your pre-screening questions…

Expert Care in Philadelphia

Access adhd specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related adhd treatment provided free

Apply for This Philadelphia Location

Check if you qualify for this adhd clinical trial in Philadelphia, PA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Philadelphia

    Convenient for PA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Philadelphia site if eligible
  4. 4Begin participation

About This ADHD Study in Philadelphia

The study aims to verify if the Gaize ocular device can effectively identify eye movements indicative of prescribed psychotropic medication usage by employing Drug Recognition Expert (DRE) testing protocols within a controlled virtual environment.

Sponsor: Gaize

Who Can Participate

Inclusion Criteria

Adults aged between 18 and 65, having given written informed consent to participate in the research trial.
Currently using a psychiatric medication as prescribed by a healthcare professional for longer than 3 months.
Normal or corrected to normal vision using either glasses or contact lenses, or surgery.

Exclusion Criteria

Enrolled in, or participated in another clinical trial within 30 days before the study
Having a prosthetic eye, missing eye, or wearer of an eye patch LASIK or other eye surgery within the prior 21 days.
Had your eyes dilated by a medical doctor in the previous 24 hours.
Photosensitive epilepsy
Diagnosed with clinical blindness
Medical Conditions: Participants with medical conditions or medications that could significantly affect cognitive and motor functions are excluded. Participants with conditions such as Glaucoma, macular degeneration, cataracts, lazy eye (amblyopia), or optic neuritis, or genetic anisocoria (unequal pupil size) will be excluded.
Current or past head inject/ traumatic brain injury (TBI)
Pregnancy: Pregnant individuals will be excluded from the study due to the potential risks associated with psychiatric medications.
History of Severe Motion Sickness: Participants with a history of severe motion sickness in VR environments may be excluded, as they may not tolerate the VR headset well.
Potential participants who are unable to provide consent for the study.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Philadelphia?

Yes, this clinical trial (NCT07389473) has an active research site in Philadelphia, PA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

ADHD Treatment Options in Philadelphia, PA

If you're searching for adhd treatment options in Philadelphia, PA, this clinical trial (NCT07389473) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Philadelphia research site is actively enrolling participants for this clinical trial. You'll receive care from experienced adhd specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all adhd clinical trials near you to find additional studies recruiting in your area.

More Alzheimers Disease Trials in Philadelphia, PA

See all alzheimers disease clinical trials recruiting in Philadelphia — not just this study.

Browse Alzheimers Disease Trials in Philadelphia →

Browse More Trials by Condition

Alzheimers Disease TrialsHuntingtons Disease TrialsADHD TrialsAtopic Dermatitis TrialsAll Conditions →

Ready to Join in Philadelphia?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Philadelphia, PA